Three big questions AI helps to answer in drug development process

February 27, 2023

Three big questions AI helps to answer in drug development process

There are three big questions in any industry, including pharmaceuticals & clinical trials:

  • How to save time?
  • How to save money?
  • How to improve the quality?

Artificial intelligence is one of the new answers to all of them. Here are a few examples:

When it comes to saving time, AI is here to take over data processing – fishing for answers to most minor questions in huge data loads, comparing records, and even making decision-leading suggestions. In Flex Databases Pharmacovigilance, for example, AI takes over signal detection by analysing cases and highlighting possible signals with matching conditions and reactions.

In addition, AI can process enormous amounts of data and build predictive analysis, which allows for forecasting patient deterioration and avoiding emergencies. AI assists in site selection and patient search making huge and complicated studies meet the deadlines and be time efficient. 

There are many aspects to using AI to save money, and the easiest thing is taking over routine tasks. By automating routine, you get to free important FTE of your employees – and redistribute it to more essential and valuable duties. 

Another example is from our AI-powered automation in the Pharmacovigilance module: the system takes care of medical coding of cases by itself, saving time on case management & minimizing human error for a higher quality of the end data. 

Ruling out human error is one of the main goals and outcomes of improving data and process quality with artificial intelligence. AI can analyse large amounts of data and identify patterns humans might miss. By automating data analysis, AI can help reduce the risk of errors caused by human oversight or bias. AI can also help extract and analyse relevant data from unstructured sources, such as medical records or literature reviews, assisting researchers in making more informed decisions.

And, well, it won’t get tired and is ready to run with close attention to detail 24/7, 365 days in a row. 

By automating processes, reducing human error, and improving decision-making, AI can help make clinical trials more efficient, effective, and safe. We have already implemented it heavily within the Flex Databases system and look forward to adding more power and broadening its use. 

Shall we see together what the future holds?

Blog

February 19, 2025
Enhancements to Investigators & Sites Management and Trial Master File

At Flex Databases, we are committed to delivering cutting-edge solutions that streamline clinical trial management. Our latest updates bring powerful enhancements to the Investigators & Sites Management module and Trial Master File, helping users gain better insights, improve workflows, and ensure seamless compliance. Investigators & Sites Management: Stay Ahead with a Powerful Dashboard Our newly […]

February 13, 2025
Maximize Efficiency with the Data Deletion Tool

The Data Deletion Application is an advanced tool that helps organizations manage storage, meet regulations, and improve data security. It allows secure removal of entire studies from Trial Master File storage, giving businesses full control over sensitive information. Key Benefits Seamless & Secure Data Management Comprehensive Data Removal The application permanently deletes: Complete Transparency & […]

February 11, 2025
eTMF to arrange your Quality Review of Folder Completeness 

It’s been out for some time now – Quality Review in eTMF of Flex Databases. But though we started with document review initially we expended this feature to folder completeness review capabilities.  Key Benefits of the Folder Completeness Review The Folder Completeness Review feature provides a structured and efficient approach to TMF quality management. By […]

February 6, 2025
Palobiofarma Chooses Flex Databases for Pharmacovigilance Management 

Palobiofarma is a leading clinical-stage biotech company dedicated to developing innovative medicines. Our focus on adenosine signaling drives our commitment to scientific excellence, with six drug candidates currently in different phases of development. Among them, PBF-999 for Prader-Willi Syndrome stands out as a key project. Our mission is to advance patient care by leveraging cutting-edge […]

Contact us

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.